Allison Marquis
Dermatology · Castle Rock, CONPI 1124664248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,417 and has fallen 58.6% since, to $587 in 2025.
Across 242 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$808
- AbbVie$726
- Sun Pharmaceutical Industries Inc.$562
- UCB, Inc.$349
- Arcutis Biotherapeutics, Inc.$332
- Novartis$265
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$271%
- Food & beverage$4,84992%
- Education$4208%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $808 |
| AbbVie | 44 | $726 |
| Sun Pharmaceutical Industries Inc. | 24 | $562 |
| UCB, Inc. | 16 | $349 |
| Arcutis Biotherapeutics, Inc. | 14 | $332 |
| Novartis | 16 | $265 |
| Regeneron Healthcare Solutions, Inc. | 9 | $263 |
| Incyte Corporation | 10 | $220 |
| Sanofi | 9 | $210 |
| Lilly USA, LLC | 8 | $203 |
| Pfizer | 11 | $192 |
| LEO Pharma Inc. | 11 | $176 |
| E.r. Squibb & Sons, L.L.C. | 5 | $127 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Amgen | 5 | $119 |
| Galderma Laboratories, L.p. | 6 | $96 |
| Almirall LLC | 3 | $87 |
| VYNE Pharmaceuticals Inc. | 2 | $73 |
| Biofrontera Inc. | 3 | $67 |
| Organogenesis Inc. | 3 | $62 |
| Dermira, Inc. | 3 | $48 |
| Organon | 5 | $43 |
| Convatec Inc. | 1 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| Acera Surgical, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $21 |
| Boston Scientific | 1 | $17 |
| Kerecis Limited | 1 | $15 |
| Journey Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,296 in reported general payments places this provider in the 70th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 13 | $952 |
| Clobetasol Propionate | 23 | $789 |
| Triamcinolone Acetonide | 39 | $391 |
| Ketoconazole | 19 | $304 |
| Hydroxyzine Hcl | 18 | $109 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Castle Rock
- Jason MamminoCastle Rock$9K
- Marcjonathan SerotaLittleton$3.2M
- Ammon LarsenLoveland$620K
- Victoria MossColorado Springs$473K
- Sheila BoyleWestminster$240K
- Mary Margaret KoberGlenwood Springs$202K
- Cathy KogerBoulder$182K
- Mona SadeghpourLone Tree$159K
- David NorrisAurora$156K
- Drew TaylorDenver$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.